As it does every year, this past week, the American Diabetes Association convened its Scientific Sessions to bring together leaders in the diabetes space. At last year’s event, next-generation technologies from the big hitters took the spotlight. The 83rd iteration this past week produced a range of new studies, product updates and positive news for […]
Virta Health
Study shows health equity impact from Virta Health diabetes reversal platform
Virta Health announced that real-world data for its diabetes reversal platform demonstrated narrowing gaps in care. The company shared its data at the American Diabetes Association’s 83rd Scientific Sessions. The research highlighted its impact on health equity. It demonstrated significant health improvement and medication reduction for members in the most and least disadvantaged U.S. neighborhoods. […]
7 innovative digital health offerings to treat diabetes
From using your smartphone to track data to reversing your diabetes altogether, these digital health technologies stand out. Advances in treatments for diabetes never stop coming. Whether that be in the form of insulin pumps or continuous glucose monitors, we’ve seen plenty. Moving away from the physical device, innovations in the digital diabetes space continue […]
Virta Health diabetes reversal produces positive outcomes in 90-day study
Virta Health announced today that a partnership with U-Haul demonstrated positive outcomes from its type 2 diabetes reversal treatement. San Francisco-based Virta — launched in 2017 — aims to reverse type 2 diabetes. It designed its technology platform to enable personalized remote care. Its offerings include physician supervision, health coaches, an app and biomarker tracking […]
The biggest stories from the American Diabetes Association (ADA) 2022 Scientific Sessions
For the 82nd time, the American Diabetes Association (ADA) Scientific Sessions convened to highlight all the innovations within the diabetes technology space. Major players like Dexcom, Medtronic, Abbott, Insulet and more continue to plug along, while companies like Bigfoot Biomedical, One Drop and others shared data backing the technology that they bring to the table. […]
Virta Health reports positive results from diabetes reversal study
Virta Health announced today that its diabetes reversal treatment demonstrated improvements in those with type 2 diabetes. San Francisco-based Virta Health launched in 2017 with the goal of reversing Type 2 diabetes using its technology platform to enable personalized remote care. Virta’s offerings include physician supervision, health coaches, an app and biomarker tracking tools, as well […]
Virta Health touts triple-digit growth with insurers as market shifts toward diabetes reversal
Virta Health announced today that it now works with more than 20 national and regional health plans, marking triple-digit growth. San Francisco-based Virta Health, which develops type 2 diabetes reversal technology, has now grown 133% year-over-year with large insurer customers that now offer its treatment to self-funded employer groups, including Humana and Providence Health Plan. […]
Virta Health touts one-year outcomes for diabetes reversal tech in Native American tribal nation
Virta Health announced today that one-year outcomes for its diabetes reversal tech proved successful on a number of levels. San Francisco-based Virta’s results came from its multi-year partnership with the Mashantucket Pequot Tribal Nation. Native Americans suffer from the highest rates of type 2 diabetes compared to any other ethnic group in the country, with […]
Virta Health raises $133M Series E for diabetes reversal tech
Virta Health announced today that it raised $133 million in a Series E equity financing round led by Tiger Global. San Francisco-based Virta said in a news release that the funds will accelerate its efforts to drive the adoption of its telehealth-based diabetes reversal treatment that aims to reverse the chronic disease while removing the […]
Virta Health touts study of treatment preventing progression to Type 2 diabetes
Virta Health announced today that a study of its diabetes progression prevention treatment proved more effective than initially expected. Peer-reviewed research in Nutrients highlighted the fact that only 3% of trial participants progressed to Type 2 diabetes, while over half achieved prediabetes reversal during the first two years, according to a news release. Additionally, the […]
